Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Heranova: Detecting endometriosis in the blood like it’s cancer

The Massachusetts-based company launched a microRNA-based liquid biopsy test for endometriosis, with an eye toward disease monitoring and drug development

March 27, 2025 11:13 PM UTC

Heranova thinks the similarities between endometriosis and cancer will make the notoriously difficult-to-diagnose disease amenable to non-invasive detection via liquid biopsy of nucleic acids from uterine lining cells undergoing excessive growth, which opens to door to use cases beyond yes/no diagnoses.

“Endometriosis behaves like a cancer,” Farideh Bischoff, CMO and head of diagnostics at Burlington, Mass-based Heranova Lifesciences Inc., told BioCentury. “The mechanisms by which this disease progresses and develops results in the shedding of material in the blood.” ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Heranova Lifesciences Inc.